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Abstract
Next generation sequencing (NGS) systems produce vast quantities of data that require substantial
computational resources for typical analysis tasks. In addition, data that are generated by different NGS systems are
not homogeneous. Moreover, there are an overwhelming number of tools available for performing typical tasks.
Managing NGS workflows involves writing custom scripts that quickly grow in complexity, often resulting in unwieldy
workflows that underutilize typical high performance compute resources, and increase the demands of the staff
managing these workflows. We present Node-Oriented Workflow (NOW), a dynamic command template workflow
engine for high performance distributed computing (HPC) systems. Our system provides a simple-to-use browser-
based front end for designing and managing complex workflows. Workflows are configured using a simple browser
interface, and are managed by the integrated job engine, which initializes nodes, monitors node status, and
processes results of individual jobs across nodes in an HPC configuration. We reduce excessive messaging across
nodes by placing the burden on nodes to start tasks in a workflow when dependencies are met, i.e., node oriented
workflow. Our system was designed for NGS processing in the clinical research setting, emphasizing user simplicity,
tool scalability, minimization of redundancy in workflows, while maximizing throughput in an HPC environment.
Furthermore, NOW is not restricted to NGS pipeline management, but can used to manage any computational
pipeline.
Keywords: High performance computing; Computational pipeline
management; Next generation sequencing; Workload distribution
Introduction
In 2005, the first massively parallel pyrosequencing platform was
made commercially available, opening the door to a new means of
conducting genetic analysis. These systems, dubbed next-generation
sequencing (NGS) systems, have made DNA sequencing more efficient
while reducing costs through automation and massive parallelization
of the sequencing processes. Most experiments that are run on NGS
systems produce enormous quantities of data. One typical whole-
genome sequencing (WGS) experiment can generate millions of reads,
or short snippets of sequenced DNA, resulting in gigabytes or even
terabytes of data, presenting enormous challenges for the analysis and
interpretation of these data. To ease the computational complexity of
WGS analysis, many researchers adopt whole-exome sequencing
(WES) for their experiments. The exome refers to ~1% of the genome
that contains the protein coding regions, i.e. the regions that are
expressed in mRNAs, which are then transcribed to proteins [1].
While the sheer volume of the data produced from a single WES
experiment is smaller, multiple experiments are often executed
simultaneously (i.e. high throughput), particularly in studies
attempting to perform some association with disease through
subsequent association studies, either genome-wide association studies
(GWAS) for common variants or some form of burden test for rare
variants. In these studies, the primary aim is to identify common
genetic variants that are associated with a specific disease or other
phenotype of interest. Accurate identification of variants is a difficult
since it is a function of read depth, read quality, mapping quality and
allele representation among the reads. The challenge of accurate
variant identification increases dramatically for rare variant detection.
Accurate variant detection often requires replication of sequencing
experiments at different levels of coverage and performing multiple
analyses with different variant calling tools. Greater depth of
sequencing and more uniform distribution of reads increases the
overall accuracy, but also the computational demand. The tools
themselves usually require repeated executions to verify the ideal tool
parameters in order to improve the probability of making the correct
call [2]. This results in even more data, placing an even greater burden
on existing compute and storage resources.
Despite their challenges, GWAS and burden test studies are
improving our understanding of the role of genetics in human disease.
Significant variants are regularly published and deposited in public
databases, adding valuable information that geneticists have at their
disposal. For example, ClinVar, which is NCBI's public archive of
variants, contains over 62,421 genetic variations (as of January 2014)
that have been accumulated from a large number of respected research
laboratories worldwide [3]. These valuable resources are being used by
geneticists in medical research to improve the likelihood of
pinpointing underlying genetic risks for common and rare diseases in
humans, including cancer and other genetic abnormalities [4,5].
Given its success in the medical research setting, NGS systems are
beginning to move beyond the lab and pure research settings, with
substantial effort being put forth to help genomic sequencing become
a part of clinical diagnosis. Here, it is increasingly being viewed as a
viable tool by the clinician to assist in diagnosis and treatment
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selection for a select number of diseases that have well studied genetic
variants identified [6]. Not only are we using these tools to identify
disease risk alleles, but it is also becoming common to use sequencing
as a proactive screening tool in high-risk cases. For example, it is
becoming more common for women with a history of breast or
ovarian cancer in one or more of their ancestors, or those with
ancestral heritage with known predisposition toward cancer (such as
Ashkenazi Jews), to proactively screen their own DNA for well-known
BRCA1 and BRCA2 mutations, allowing the clinician and patient to
assess their own risk toward developing breast and ovarian cancer [7].
In addition, the public perception toward screening for such diseases is
becoming increasingly positive, placing further demand on the use of
various forms of genetic screening in the clinical setting [8]. Though
we have many significant challenges to conquer to improve the
accuracy and reliability of variant calling, most agree that its use in
clinical diagnosis and treatment identification will only continue to
increase in the coming years [9,10].
The challenges for a clinical diagnosis pipeline
The general workflow required for individual variant calling might
seem simplistic: sequence the DNA, analyze the data to identify
variants, perform verification, and compare them against a trusted
database of known variants. The difficulty of this process does not lie
in initial step of sequencing DNA, and the cost of sequencing
instrumentation continues to drop, allowing whole-exome sequencing
to be conducted below $1,000 [11]. NGS pipelines require large, high
speed, redundant arrays of disks that are in the tens or even hundreds
of terabytes in total size, making storage and management of the data a
challenging task. There are up-front costs with the selection and
installation of these systems, but usually require comparatively
minimal user intervention once installed and configured properly.
However, these challenges pale in comparison to the challenges that
arise in the analysis of sequence data generated; these costs are
growing, with most expecting these costs to rise through the
foreseeable future [12].
NGS analysis cost is multifaceted. A portion of the cost is the
personnel skills and labor required to configure and manage these
pipelines. This is particularly true of pipelines for variant calling,
which is an immensely complex task that requires numerous
individual tasks to be performed. A typical WES workflow consists of
five primary steps: (i) quality assessment, which consists of cleaning,
filtering, and trimming of the raw data; (ii) alignment of the reads to a
reference genome; (iii) identification and classification variants; (iv)
annotation of identified variants to establish potential significance
with respect to the observed phenotype; and (v) use of tools to allow
ease of validation and verification of identified variants, including
tools for visualization. We refer the reader to the thorough survey by
Pabinger et al. [13], which presents an overview of the enormous
number of tools available for WES and variant calling. Each of these
individual steps has a large number of tools available, each with their
own strengths and weaknesses. The tools used in most settings are in
the public domain. They are complex, have a large parameter set, and
often generate individual results that are heterogeneous with other
steps in the workflow. Commercial workflows may be considered, but
they are expensive, complex, and lack the infrastructure for practical
use in the clinical setting [14]. The clinical setting would require these
workflows to be stable, and executed in a high throughput fashion,
with a rapid turnaround of results. The burden that is placed on
bioinformatics and IT personnel is evident – the task of managing
WES workflows is an immensely complex endeavor.
From an informatics viewpoint, hardware costs can be enormous
due to the compute resources required for high throughput variant
calling pipelines. Software costs are often falsely viewed as cheap
because many are freely available in the public domain. The fact is that
identifying, installing, and learning how to effectively use and manage
NGS tools for the workflow are time-consuming endeavors. Assuming
you have the proper storage facilities, and adequate compute
resources, and have all tools installed properly, the most significant
challenge lies in making the most effective use of these resources on a
daily basis in a high throughput setting.
High-performance compute servers and clusters are becoming
commonplace for NGS pipelines, requiring frameworks that are able
to manage complex workflows on these systems. Perhaps the most
comprehensive framework available is Galaxy [15]; a web-based
platform that strives to wrap an enormous number of independent
computational biomedical research tools into highly configurable
workflows configured and controlled with a browser-based user
interface. Galaxy is powerful, and designed for the research setting,
making its complexity unsuitable for the simplified, streamlined high
throughput needs required for the clinical setting. Other systems, such
as SIMPLEX, have made an effort to move the compute resources for
NGS processing to the cloud [16]. Off-site, service-oriented compute
resources such as those managed in cloud environments may offset
start-up costs, but the lack of security and privacy controls may not be
suitable for the clinical setting. Numerous other frameworks have been
released in recent years [17-20], but all have limitations that make
them unsuitable for the clinical setting, including, (i) offering a
complex command-line interface that is designed for general cluster
workflows in research settings, (ii) they are designed for a specific NGS
platform or a limited set of tools, (ii) they lack a streamlined, simple,
platform-independent interface to manage workflows and monitor
execution, (iv) they lack scalability or functionality, or both, that make
them unsuitable for use on a high performance compute platform, (v)
or they fail to provide an audit log trail facility to record workflow
parameters.
Our own experience has shown that proper selection, installation,
and management of the numerous tools and computational pipelines
that are required for NGS analyses involves numerous challenges,
requiring a dedicated staff of bioinformatics experts. Most NGS tasks
require many tools working in sequence across numerous large data
files to achieve the desired result, with each individual task requiring
its own set of parameters depending on the analysis being performed.
Making the most efficient use of existing computational resources can
be difficult, as most job control software in a grid environment can be
quite complex. These tools, most of which are in the public domain,
are difficult to configure and manage. Once jobs are spawned they
often lack the appropriate infrastructure for appropriate job
monitoring. Finally, recent studies have noted that existing tools that
are designed to accomplish the same task often generate dissimilar
results, stressing the need to run simultaneous experiments using
different parameters, or entirely different tools altogether [21].
We present Node-Oriented Workflow (NOW), a scalable,
extensible framework for the management of complex NGS workflows
in high performance distributed systems. NOW was designed with an
emphasis on scalability, simplicity, and reliability, without sacrificing
power and flexibility. With respect to an HPC configuration utilizing
multiple nodes over a network, NOW was designed with the aim of
automatic distribution of workload among nodes, while minimizing
the network traffic between nodes as jobs are run, by placing the
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burden on individual nodes to be responsible for their work. NOW is
freely available under the GPL license and can be downloaded from
https://github.com/eblipsky.
Implementation
NOW utilizes a dynamic command template workflow engine that
provides a browser-based interface designed for ease of pipeline
configuration and monitoring. At the top-most level, the user
configures a batch, which represents the work to be performed on a set
of files. More specifically, a batch contains an ordered list of pipelines
and a list of files that are required to start the first pipeline in the
batch. A pipeline is a sequential list of atomic tasks which are designed
to carry out a major job in the batch, such as mapping reads from a
WES experiment to a reference genome, or variant calling on mapped
reads. Each pipeline has one required start task, and optional
subsequent tasks that are executed in order. A task is the most
important abstraction in NOW; it wraps the information needed to
perform a single step of actual work in a pipeline. Individual tasks can
be configured by referring to a command template in the template
library, or by directly entering a command in the task window. As
pipelines are executed, task parameters are stored and associated with
its results, providing a repository of useful historical information for
each pipeline executed. On successful completion of a task, the
designated next task will execute, or its error task will start if there is a
failure. Advanced task configurations provide for optional
preprocessing or postprocessing scripts to be executed before or after,
or both before and after, the task executes. Figure 1 depicts the
hierarchical relationship between these important user-level
components in NOW.
NOW was designed to work in a high performance computing
(HPC) environment, or any platform where multiprocessing can be
utilized. Many tasks in NGS pipelines can be automated and
parallelized to fully utilize the power of modern HPC systems. NOW
provides a simple mechanism to maximize throughput with little
human interaction. Each task has optional multiprocessing hints,
which provide NOW with information on how to distribute tasks
among all nodes and processors currently available at the time a task is
scheduled to run.
The user interface to NOW is entirely browser-based, written in
standard HTML5 ensuring platform independence. The entire
configuration of a pipeline is performed through the browser,
including management of command templates (Figure 2). Once a
workflow is configured, a graph-based visualization of the workflow
can be rendered, aiding in configuration and verification of the desired
logical flow of the tasks for each pipeline. NOW is able to visualize the
workflow templates and perform asynchronous updates of page
content to allow monitoring of pipeline completion in real time
(Figure 3).
NOW is comprised of several publicly available off-the-shelf
components. We made an effort to incorporate proven, stable, publicly
available components with default installation procedures. The critical
data management backbone of the system uses Redis and CouchDB,
with the web-based user interface implemented using the Laravel PHP
framework managed with Apache as the web server. Python is used to
handle the executions of tasks within NOW, with JSON selected as the
main data sharing protocol throughout the system. The browser-based
point-and-click interface is developed with HTML following standard
AJAX technologies, with the visualization of job configuration and
management developed using jQuery and jsplumb. An audit log has
been implemented that stores the precise configuration and
completion statistics of every task that is run within NOW. The audit
log is stored and managed with CouchDB. (Figure 4 for a diagram
depicting the system configuration of NOW).
Figure 1: Hierarchy of NOW workflow components – The above
diagram shows the different components in NOW. At the highest
level, the user configures a batch of pipelines to execute on a set of
files. Pipelines encapsulate an ordered list of tasks to be carried out.
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Figure 2: Task edit window – This window shows the task editor for
configuring command templates or for directly entering a task in
the workflow. In this picture, a task is configured using a user-
defined command.
Results
NOW has been thoroughly tested and is now regularly used on our
own system here at Geisinger Health Systems, which consists of a 25
node HP Unified Cluster, with one node configured to be the head
node. There are 228 TB of attached storage from DataDirect Networks
available in the system. Each node has dual Intel Xeon processors
running at 2.60 GHz, providing 16 cores, and 128 GB of RAM per
node. In addition, nodes have NVIDIA Tesla M2090 PCIe graphics
processor cards for GPU computing.
To test the efficacy of NOW, we configured two pipelines in a batch,
designed to perform variant calling on a set of targeted resequencing
data (Figure 5). The resequencing platform was designed for the
Pharmacogenomics Research Network (PGRN) [22] and comprises
the exonic sequences from 84 genes that are known to have substantial
pharmacological impact in human drug metabolism, as is named the
PGx platform. The data represent PGx sequences generated for 96
individuals. One PGx resequencing dataset contains approximately
12.8 GB paired-end reads sequenced at 500 fold coverage, yielding a
total of 500 million bases.
Figure 3: Pipeline visualization – This screen visualizes a pipeline
that completes an alignment of reads to a reference. The pipeline is
implemented in four distinct tasks.
Figure 4: System Configuration of NOW – The interaction and
dependencies between important components of NOW are
displayed in this figure. In general, data obtained from an NGS
system are copied over to the HPC file storage facilities. NOW
administrative tools are used to register these files in the
framework. The web server provides the front end to the system,
allowing users to create pipelines and start processing of registered
files.
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Figure 5: Batch configuration for variant calling – A single batch
consisting of two pipelines for variant calling from whole exome
sequence data are shown. The first pipeline performs the mapping
of the reads to the reference genome, and the second performs
variant calling from the mapped data.
The first pipeline in the batch performed the mapping of all of the
paired-end reads to the human genome, reference GRCh37. BWA [23]
was used to perform the alignment of the reads to the reference. The
resulting SAM file was sorted and indexed using samtools [24],
yielding a BAM file of aligned reads. These data were then sent to the
second pipeline in the batch for variant calling. In this pipeline, GATK
was used to recalibrate base quality scores and to perform the actual
variant calling using the latest reference of human variation from
NCBI dbSNP's repository [25]. Finally, the resulting VCF files were
then postprocessed using VCFtools to generate reports and perform
statistical analyses [26].
As a baseline for comparison purposes, we executed the batch job
for a single exome dataset from a manual script in a strict sequential
fashion, restricting all computational resources requested from the
program to one node. No other jobs were executing on the node, and
no other nodes were utilized. The entire batch took approximately two
hours and 10 minutes to complete on this system configuration.
Specifically, the alignment pipeline took one hour to complete, and the
variant calling pipeline completed in an hour and 10 minutes. If this
batch was performed serially on sequence data from 96 HapMap
reference DNA specimens without using NOW, it would have taken
over 8 days to complete. We reran the same experiment, utilizing a
total of 10 nodes. Under this configuration, using NOW, all 96 files
were processed in 6 hours. If no multiprocessing enhancements in
NOW were utilized, and all 96 batches were allowed to run in
sequential fashion over 10 nodes, this would have still required
approximately 20 hours to complete. NOW’s multiprocessing
improvements allowed the same work to be completed in only 30% of
the time, maximizing CPU utilization and overall data throughput in
both pipelines.
Discussion
There are several important criteria that influenced the design of
NOW. Our first goal was to provide a scalable platform not tied to any
specific toolset or sequencing instrumentation. There is no dearth of
tools available for NGS processing. Moreover, the field is nascent, and
continues change rapidly. We needed a tool that was able to utilize a
wide range of NGS tools available, and be free of any tie to a specific
NGS platform, data format, or tool set. NOW provides this flexibility
through the task abstraction. A NOW task represents any general
command, analogous to a command that would execute from the
command line or from within a custom script. This is ideal for
majority of our users; most bioinformatics tools we use, particularly
those for NGS processing, are command-line driven. This flexibility
opens NOW to be used for a wide range of computational tasks, not
just those dominated by NGS systems.
Another important design goal was to minimize dedicated staff for
NGS workflows management. As a clinical diagnostic lab, with
numerous tasks to handle with minimal bioinformatics support staff,
we could not afford dedicated staff that constantly monitors job
submission, status, and completion to maximize job throughput.
Moreover, many individual jobs are highly similar, requiring only
minimal parameter changes from one job to the next. By creating a
template-based system, pipeline similarities are captured through the
command templates, allowing the user to focus only on parameter
alterations needed for each job by eliminating the complexity of
writing and managing custom scripts. Moreover, multiple batches can
be submitted to NOW. NOW is autonomous; each node monitors its
own state and resource availability, maximizing throughput around
the clock. In the event of errors in individual tasks, the job engine
notifies the user via e-mail, and continues to process other jobs
ensuring maximal throughput.
A third important design goal was to provide scalability and
flexibility with respect to the underlying commands and tools used in
any given pipeline. As a clinical medical research group, our
responsibilities with NGS processing can be varied, and conflicting.
We evaluated several existing pipeline / workflow frameworks;
however, none of them were found to meet our needs. We found
existing systems to be either too advanced, meaning, they were
designed solely for the pure research setting, or too restrictive,
designed to run with a specific toolset or platform. Some systems
expected the user to follow its built-in workflow. We needed a simple,
easy to use, lightweight tool to manage a wide range of NGS
workflows. Nevertheless, our experience has shown that there is
nothing simple about NGS workflows, especially in a HPC system.
NOW offers the flexibility needed without sacrificing throughput.
Our final design goal was the incorporation of an audit log system.
NOW incorporates a logging system within the same CouchDB and
JSON framework that is used throughout the system. NOW will log
the precise command line that was executed for every task within
every workflow managed by the framework. Additionally, it logs
important execution statistics, including the node that the task was
executed on, start and stop times, CPU usage, task output, and
successful completion status. The audit logger provides the
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mechanism to record how a workflow is executed, easing the burden
of identifying and fixing individual task or node failures.
An important distinction between NOW and other similar
workflow systems lies in the placement of the responsibility of task
execution. A typical setup in an HPC system places responsibility on
one head node to constantly monitor the state of all tasks executing on
all nodes in the cluster, and executes new tasks as resources become
available. NOW follows a different approach, making each node
responsible for monitoring its own state and running tasks that are
appropriate given its current load. This approach substantially
decreases messaging overhead between one head node and the rest of
the nodes in the system.
We anticipate that future improvements will be made to the NOW
framework through our own internal efforts, as well as the efforts of
the open source community. One possible improvement to the
existing framework would be to provide some restricted capabilities
for end users that are not part of the bioinformatics staff to utilize
NOW for their own processing needs. To this end, NOW could be
modified to create an abstraction layer over each task that hides much
of the configuration options that are normally available to the
bioinformatics staff. This would provide access to power and flexibility
of the computational resources that NOW manages, while only
exposing those parameters that are appropriate for end users, such as
the location of their data files.
Conclusion
Next generation sequencing has brought forth a plethora of
methods used to identify interpretable mutations that are associated
with disease and other clinical phenotypes with high confidence.
Coincidentally, interest in genetic screening for predisposition and
diagnostic explanation of various phenotypes has surged at both
clinical and research levels. The computational pipelines required to
perform these services are complex, requiring substantial compute and
storage resources, in addition to dedicated bioinformatics support
staff. These costs can be prohibitive, necessitating a streamlined
framework that can maximize throughput while minimizing continual
support from dedicated staff. In this paper, we presented NOW, a
framework for managing high-throughput pipelines required to
perform complex computational analyses. NOW creates a web-based
user interface to create and manage pipelines having a wide range of
complexity, providing numerous abstractions that hide the intricacy of
the tools used to perform these analyses. The system can run in either
a standalone or HPC environment, utilizing as many nodes and
processors as possible to maximize throughput. NOW was developed
based on the needs of our own clinical and research facilities to
execute whole genome and exome experiments with rapid turnaround
times. In addition, the framework offers the flexibility to be used on
any computational pipeline where HPC systems are available.
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